| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06.06 | Novartis Launches Global Program Expanding Access to Investigational Compound Nilotinib (AMN107) for Patients With Hard-to-Treat Leukemia | 45 | PR Newswire | EAST HANOVER, N.J., June 4 /PRNewswire/ -- Novartis announced today the launch of a global program, ENACT (Expanding Nilotinib Access in Clinical Trials), to provide expanded access to nilotinib (AMN107)... ► Artikel lesen | |
| 04.06.06 | Addition of VELCADE(R) (Bortezomib) for Injection Improved survival in Front-Line Advanced Lung Cancer | 31 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced the final results from a Phase II study conducted by the Southwest Oncology Group (SWOG) that showed a median... ► Artikel lesen | |
| 04.06.06 | Results of Phase II Studies Measure Progression Free Survival for ZACTIMA (ZD6474) in Lung Cancer | 33 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- AstraZeneca announced today the results of two Phase II studies, Trial 003 and 006, with ZACTIMA (ZD6474), a compound which targets both epidermal growth... ► Artikel lesen | |
| 04.06.06 | GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research | 59 | PR Newswire | PHILADELPHIA, NEW YORK, and LONDON, June 4 /PRNewswire-FirstCall/ -- GlaxoSmithKline and the international Ludwig Institute for Cancer Research (LICR) today announce they have entered into an agreement... ► Artikel lesen | |
| 04.06.06 | Encouraging Results of a Clinical Study With GSK's Novel Cancer Immunotherapy Report Activity in Patients With Most Common Form of Lung Cancer | 41 | PR Newswire | PHILADELPHIA, June 4 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that interim results from a clinical trial in patients treated with GSK's investigational MAGE-A3 Antigen Specific Cancer... ► Artikel lesen | |
| 04.06.06 | Metabasis Therapeutics Presents Poster at American Society of Clinical Oncology | 24 | PR Newswire | SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Metabasis Therapeutics, Inc. announced today that a poster entitled, "A Phase I/II Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of... ► Artikel lesen | |
| 04.06.06 | Lilly Announces Phase II Results for ALIMTA(R) in First-Line Metastatic Breast Cancer Trial | 17 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- At the 42nd American Society of Clinical Oncology (ASCO) annual meeting in Atlanta, Ga., Eli Lilly and Company announced results of a Phase II trial evaluating... ► Artikel lesen | |
| 04.06.06 | New Data Show Enzastaurin's Activity Across Multiple Cancer Cell Lines | 71 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for... ► Artikel lesen | |
| 04.06.06 | VELCADE(R) (Bortezomib) for Injection May Offer New Standard of Care in Relapsed/Refractory Mantle Cell Lymphoma | 17 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced results of a clinical study that showed the efficacy of single-agent VELCADE in the treatment of relapsed... ► Artikel lesen | |
| 04.06.06 | VELCADE(R) (Bortezomib) for Injection Demonstrated High Single-Agent Response Rates in Newly Diagnosed Multiple Myeloma Patients | 21 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced new clinical data for the treatment of multiple myeloma (MM) that underscore the potential benefit of using... ► Artikel lesen | |
| 04.06.06 | Data from XYOTAX STELLAR Trials Presented at 2006 Meeting of American Society of Clinical Oncology | 37 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- At the 2006 Annual Meeting of the American Society of Clinical Oncology (ASCO), data from Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC; MTAX) phase III STELLAR... ► Artikel lesen | |
| 04.06.06 | The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. Announce Positive Early Results in Development of Genomic Test for Colon Cancer Prognosis | 39 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- The Pittsburgh-based National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. today announced positive results of a new study... ► Artikel lesen | |
| 04.06.06 | Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel | 40 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Data presented today at the 42nd American Society of Clinical Oncology (ASCO) annual meeting in Atlanta, Ga., affirms that ALIMTA(R) (pemetrexed), manufactured... ► Artikel lesen | |
| 04.06.06 | Introgen's INGN 241 in Combination With Tarceva Inhibits Tumor Growth | 20 | PR Newswire | BALTIMORE, June 4 /PRNewswire-FirstCall/ -- Studies by researchers at Introgen Therapeutics, Inc. and their collaborators at The University of Texas M. D. Anderson Cancer Center show that the combination... ► Artikel lesen | |
| 04.06.06 | Wyeth Announces Preliminary Results of an Ongoing Study of Temsirolimus for the Treatment of Advanced Renal Cell Carcinoma as Presented at ASCO | 28 | PR Newswire | MADISON, N.J., June 4 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that preliminary data from an interim analysis of its ongoing phase 3 clinical trial of... ► Artikel lesen | |
| 04.06.06 | The Stars Shine as MTV Celebrates Hollywood's Biggest Blockbuster, The '2006 MTV Movie Awards' | 37 | PR Newswire | CULVER CITY, Calif., June 4 /PRNewswire/ -- In an evening filled with action, mystery, music and hijinks, MTV rolled out the carpet to welcome the stars and celebrities for Hollywood's most anticipated... ► Artikel lesen | |
| 04.06.06 | Labor Negotiations Cease with CAW Local 1941 at ArvinMeritor's Brake Facility in Tilbury, Ontario | 14 | PR Newswire | TROY, Mich., June 4 /PRNewswire/ -- ArvinMeritor, Inc. announced today that a tentative agreement was not reached with the Canadian Auto Workers (CAW) Local 1941 union bargaining committee at the... ► Artikel lesen | |
| 04.06.06 | Tiny Terror Kicks Tail: Los Angeles' Top Chihuahua Advances to America's Fastest Chihuahua Championship Race in San Diego | 18 | PR Newswire | LOS ANGELES, June 3 /PRNewswire/ -- They might be America's smallest breed of dog, but they sure are lightning-quick. Chihuahuas of all sizes came together today to compete for the coveted title of... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 3.645 |
| RHEINMETALL | 3.318 |
| NVIDIA | 3.215 |
| VARTA | 3.154 |
| NEL | 2.853 |
| TESLA | 2.448 |
| RENK GROUP | 2.194 |
| DEUTSCHE LUFTHANSA | 2.086 |
| BAYER | 2.074 |
| SUPER MICRO COMPUTER | 2.061 |
| AIXTRON SE | 1.687 |
| BYD | 1.578 |
| BASF | 1.227 |
| DEUTSCHE BANK | 1.227 |
| NETFLIX | 1.099 |
| EVOTEC | 1.079 |
| RWE | 1.060 |
| COMMERZBANK | 981 |
| SARTORIUS AG VZ | 961 |
| PLUG POWER | 918 |
| BARRICK GOLD | 915 |
| ALLIANZ | 891 |
| INFINEON | 884 |
| MERCEDES-BENZ | 883 |
| THYSSENKRUPP | 881 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
